Publicaciones (75) Publicaciones de Francisco Javier Novo Villaverde

2023

  1. Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model

    Cells, Vol. 12, Núm. 1

  2. Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma

    Journal for immunotherapy of cancer, Vol. 11, Núm. 2

2020

  1. The Theory of Evolution in the Writings of Joseph Ratzinger

    Scientia et fides, Vol. 8, Núm. 2, pp. 323-349

2019

  1. Hacia la mejora genética de seres humanos

    Nuestro tiempo, Núm. 702, pp. 28-35

  2. The nature of traits, genes and variation

    Principles of Nutrigenetics and Nutrigenomics: Fundamentals of Individualized Nutrition (Elsevier), pp. 3-9

2018

  1. Evolución: [para creyentes y otros escépticos]

    Rialp

  2. Naturaleza creativa

    Rialp

2017

  1. p.Y317H is a new JAK2 gain-of-function mutation affecting the FERM domain in a myelofibrosis patient with CALR mutation

    Haematologica

2014

  1. A simple approach for classifying new mutations as somatic or germinal in DNA samples lacking paired tissue

    BioTechniques, Vol. 56, Núm. 6, pp. 327-329

  2. Bioinformatic analyses of CALR mutations in myeloproliferative neoplasms support a role in signaling

    Leukemia

  3. Habit acquisition in the context of neuronal genomic and epigenomic mosaicism

    Frontiers in Human Neuroscience

  4. La ciencia conquista el futuro

    Nuestro tiempo, Núm. 684, pp. 6-15

2013

  1. CBL RING finger deletions are common in core-binding factor acute myeloid leukemias

    Leukemia and Lymphoma

  2. El misterio de la vida en un mecano

    Nuestro tiempo, Núm. 679, pp. 71-71

  3. Oncofuse: A computational framework for the prediction of the oncogenic potential of gene fusions

    Bioinformatics, Vol. 29, Núm. 20, pp. 2539-2546

2012

  1. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia

    Leukemia and Lymphoma

  2. CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2

    Haematologica, Vol. 97, Núm. 8, pp. 1234-1241

  3. Chronic cyclic nonnephrogenic magnesium depletion without losses

    New England Journal of Medicine

  4. Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer

    PLoS Computational Biology, Vol. 8, Núm. 12

2011

  1. LIF, a novel STAT5-regulated gene, is aberrantly expressed in myeloproliferative neoplasms

    Genes and Cancer, Vol. 2, Núm. 5, pp. 593-596